Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effects of Renin Angiotensin System Blockage (RAS), Calcium Channel Blocker and Combine Drugs on TWEAK, PTX3 and FMD Levels in Diabetic Proteinuric Patients With Hypertension

NCT00921570 is registered in ClinicalTrials.gov with Gulhane School of Medicine as lead sponsor.

NCT NCT00921570
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00921570 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effects of Renin Angiotensin System Blockage (RAS), Calcium Channel Blocker and Combine Drugs on TWEAK, PTX3 and FMD Levels in Diabetic Proteinuric Patients With Hypertension
Lead sponsor
Gulhane School of Medicine
Phase
Phase 4
Overall status
Completed
Start date
February 29, 2008
Completion date
May 31, 2009
Enrollment
105 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes, hypertension, proteinuria